References
1. Environmental tobacco smoke and lung cancer: an evaluation of the risk: report of a European working group. Trondheim: Trondheim European Working Party, 1996. Chairman: JR Idle.
2. Department of Health. The health of the nation: smoke-free for health: an action plan to achieve the health of the nation targets. London: Department of Health, 1994; 59.
3. EPA. Respiratory health effects of passive smoking: lung cancers and other disorders: US Environmental Protection Agency. Washington: Office of Air and Radiation, 1992. (EPA/600/6-90/006F).
4. World Health Organisation. International agency for research on cancer: IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: Tobacco smoking. Pub. IARC, Lyons 1986: 421. (vol 38)
5. National Resesearch Council. Environmental tobacco smoke: measuring exposures and assessing health effects: Committee on Passive Smoking Board on Environmental Studies and Toxicology. Washington DC: National Academy Press, 1986.
6. Independent Scientific Committee on Smoking and Health: fourth report. London: HMSO, 1988.
7. Armitage A K, Ashford J R, Gorrod J W, Sullivan F M. Environmental tobacco smoke: is it really a carcinogen. Medical Science Research 1997; 25: 3-7.
8. Lee P N. Passive smoking and lung cancer association: a result of bias? Human Toxicol 1987; 6: 78-85.
9. Fleiss J L, Gross A J. Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991; 44: 127-139.
10. Tobacco Manufacturers Association. A review of the epidemiology of ETS and lung cancer. Unpublished report submitted to SCOTH, 1996.
11. Nilsson R. Review of environmental tobacco smoke and lung cancer: a reappraisal. Ecotoxicol Environ Safety 1996; 34: 2-17.
12. Department of Health. Report on health and social subjects: guidelines for the evaluation of chemicals for carcinogenicity: Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment. London: HMSO, 1991; 80. (vol 42).
13. Bradford-Hill A. The environment and disease: association or causation? Proceedings of the Royal Society of Medicine 1965; 58: 295-300.
14. World Health Organisation. Tomatis L, ed. Cancer: causes occurrence and control. Lyon: International Agency for Research on Cancer, 1990; 352. (IARC Scientific publication no 100)
15. Guerin M R, Jenkins R A, Tomkins B A. The chemistry of environmental tobacco smoke: composition and measurement. Michigan: Lewis, 1992.
16. Guerin M R. Formation and physical nature of sidestream smoke. In: O'neill I K, Brunnemann K D, Bodet B, Hoffmann D, eds. Environmental carcinogens methods of analysis and exposure measurement. Lyon: International Agency for Research on Cancer, 1987; 11-24. (Passive smoking; vol 9). (IARC Scientific publication no 81).
17. McAughey J. Environmental tobacco smoke: a critical review of the dosimetry. AEA Technology plc, Harwell. Unpublished report produced for the Tobacco Manufacturer's Association, 1997.
18. Baker R R, Procter C J. The origins and properties of environmental tobacco smoke. Environ Intern 1990; 16: 231-45.
19. Eatough D J, Hansen L D, Lewis E A. The chemical characterisation of environmental tobacco smoke. Environ Technol 1990; 11: 1071-85.
20. Gori G B, Mantel N. Mainstream and environmental tobacco smoke. Regul Toxicol Pharmacol 1991; 18: 88-105.
21. Rawbone R R, Burns W, Haslett G. The aging of sidestream tobacco components in ambient environments. Indoor Air Quality 1990: 55-61.
22. Brunnemann K D, Yu L, Hoffmann D. Assessment of carcinogenic volatile nitrosamines in tobacco and in mainstream and sidestream smoke from cigarettes. Cancer Res 1977; 37: 3218-22.
23. Hoffmann D, Adams J D, Brunnemann K D, Hecht S S. Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res 1979; 39: 2505-9.
24. Adams J D, O'Mara-Adams K J, Hoffmann D. Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis 1987; 8: 729-31.
25. Lofroth G. Environmental tobacco smoke: overview of chemical composition and genotoxic components. Mutat Res 1989; 222: 73-80.
26. Department of Health. In confidence report on determination of tobacco specific nitrosamines in mainstream and sidestream smoke of cigarettes. Teddington: Unpublished report by the Laboratory of the Government Chemist, 1994.
27. Chortyk O, Schlotzhauer W S. The contribution of low tar cigarettes to environmental tobacco smoke. J Anal Toxicol 1989; 13: 129-34.
28. Patrianakos C, Hoffmann D. Chemical studies on tobacco smoke LXIV: on the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 1979; 3: 150-4.
29. Sterling T D, Mueller B. Concentrations of nicotine RSP, CO and CO2 in non-smoking areas of offices ventilated by air recirculated from smoking designated areas. American Industrial Hygiene Association J 1988; 49: 423-6.
30. Turner S, Cyr L, Gross A J. The measurement of environmental tobacco smoke in 585 offices. Environ Intern 1992; 18: 19-28.
31. Oldaker G B, Taylor W D, Parish K B. Investigations of ventilation, smoking activity, and indoor air quality at four large office buildings. In: Proceedings of indoor air quality 1993. ASHRE, 1992; 248-57.
32. Hedge A, Erickson W A, Rubin G. The effects of alternative smoking policies on indoor air quality in 27 office buildings. Ann Occup Hyg 1994; 38: 265-78.
33. Scherer G, Conze C, Tricker A R, Adlkofer F. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS). Clin Investig 1992; 70: 352-67.
34. Phillips K, Howard D A, Browne D, Lewsley J M. Assessment of personal exposures to environmental tobacco smoke in British non-smokers. Environ Intern 1994; 20: 693-712.
35. Jenkins R A. Determination of personal exposure of non-smokers to environmental tobacco smoke in the United States. Lung Cancer 1996; 14(suppl): S195-S213.
36. Phillips K et al. Assessment of air quality in Stockholm by personal monitoring of non-smokers for respirable suspended particles and environmental tobacco smoke. Scand J Work Environ Health 1996; 22(suppl 1): 1-24.
37. Holocomb L C. Indoor air quality and environmental tobacco smoke: concentration and exposure. Environ Intern 1993; 19: 9-40.
38. Husgafvel-Pursiainen K, Sorsa M, Moller M, Benestad C. Genotoxicity and polynuclear aromatic hydrocarbon analysis of environmental tobacco smoke samples from restaurants. Mutagenesis 1986; 1: 287-92.
39. Salomaa S, Tuominen J, Skytta E. Genotoxicity and PAC analysis of particulate and vapour phases of environmental tobacco smoke. Mutat Res 1988; 204: 173-83.
40. Brunnemann K D, Cox J E, Hoffmann D. Analysis of tobacco-specific N-nitrosamines in indoor air. Carcinogenesis 1992; 13: 2415-18.
41. Wallace L A, Pellizzari. Personal air exposures and breath concentrations of benzene and other volatile hydrocarbons for smokers and non-smokers. Toxicol Lett 1986; 35: 113-16.
42. Heavner D L, Morgan W T, Ogden M W. Determination of volatile organic compounds and ETS apportionment in 49 homes. Environ Intern 1995; 21: 3-21.
43. Brown V, Crump D R. Volatile organic compounds. In: Berry RW, ed. Indoor air quality in homes: part 1: the building research establishment indoor environment study. London: Construction Research Communications, 1996; 38-62.
44. Hoffmann D, Adams J D, Brunnemann. A critical look at N-nitrosamines in environmental tobacco smoke. Toxicol Lett 1987; 35: 1-8.
45. Hecht S S, Carmella S G, Murphy S E, Akerkar S, Brunnemann K D, Hoffmann D. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke. N Engl J Med 1993; 329: 1543-6.
46. Repace J L. Indoor concentrations of environmental tobacco smoke: models dealing with effects of ventilation and room size. In: O'neill I K, Brunnemann K D, Bodet B, Hoffmann D, eds. Environmental carcinogens methods of analysis and exposure measurement: passive smoking. Lyon: International Agency of Research on Cancer, 1987; 25-42. (IARC Scientific publication no 81).
47. Repace J L, Lowrey A H. Indoor air pollution, tobacco smoke and public health. Science 1980; 208: 464-72.
48. Hammond S K, Leaderer B P, Roche A C, Schenker M. Collection and analysis of nicotine as a marker for environmental tobacco smoke. Atmospheric Environ 1987; 21: 457-62.
49. Hiller F C, McCusker K T, Mazumder M K, Wilson J D, Bone R C. Deposition of sidestream cigarette smoke in the human respiratory tract. Am Rev Respiratory Disease 1982; 125: 406-8.
50. Hinds W, First M W, Huber G L, Shea J W. A method for measuring respiratory deposition of cigarette smoke during smoking. Am Ind Hyg Assoc J 1983; 44: 113-18.
51. Department of Health. Committee on the Medical Effects of Air Pollutants: non biological particles and health. London: HMSO, 1995.
52. Oberdorster G, Pott F. Extrapolation from rat studies with environmental tobacco smoke (ETS) to human: comparison of particle mass deposition and of clearance behaviour of ETS compounds. Toxicol Lett 1987; 35: 107-12.
53. Grover P L. K-region epoxides of polycyclic hydrocarbons: formation and further metabolism of benz(a)anthracene 5,6: oxide by human lung preparations. FEBS Lett 1973; 34: 63-8.
54. Castonguay A, Stoner G D, Schut H A J, Hecht S S. Metabolism of tobacco specific N-nitrosamines by cultured human tissues: proceedings of the National Academy of Sciences 1983; 80: 6694-7.
55. van Houdt J J, Jongen V M F, Alink G M, Boleij J S M. Mutagenic activity of airborne particles inside and outside homes. Environ Mutagenesis 1984; 6: 861-9.
56. Lfroth G, Lazaridis G. Environmental tobacco smoke: comparative characterisation by mutagenicity assays of sidestream and mainstream cigarette smoke. Environ Mutagenesis 1986; 8: 693-704.
57. Husgafvel-Pursiainen K, Sorsa M, M?ller M, Benestad C. Genotoxicity and polynuclear aromatic hydrocarbon analysis of environmental tobacco smoke samples from restaurants. Mutagenesis 1986; 1: 287-92.
58. Ling P I, Lfroth G, Lewtas J. Mutagenic determination of passive smoking. Toxicol Lett 1987; 35: 147-51.
59. Claxton L D, Morin R S, Hughes T J, Lewtas J. A genotoxic assessment of environmental tobacco smoke using bacterial bioassays. Mutat Res 1989; 222: 81-99.
60. Lfroth G, Stensman C, Brandhorst-Satzkorn M. Indoor sources of mutagenic aerosol particulate matter: smoking, cooking and incense burning. Mutat Res 1991; 261: 21-8.
61. Kado N Y, McCurdy S A, Tesluk S J, et al. Measuring personal exposure to airborne mutagens and nicotine in environmental tobacco smoke. Mutat Res 1991; 261: 75-82.
62. Chen C, Lee H. Genotoxicity and DNA adduct formation of incense smoke condensates: comparison with environmental tobacco smoke condensates. Mutat Res 1996; 367: 105-14.
63. Mohtashamipur E, Norpoth K, Straeter H. Clastogenic effect of passive smoking on bone marrow polychromatic erythrocytes of NMRI mice. Toxicol Lett 1987; 35: 153-6.
64. Lee C K, Brown B G. Fourteen day inhalation study in rats using aged diluted sidestream smoke from a reference cigarette: II DNA adducts and alveolar macrophage cytogenetics. Fundam Appl Toxicol 1992; 19: 141-6.
65. Lee C K, Brown B D. Ninety-day inhalation study in rats, using aged and diluted sidestream smoke from a reference cigarette: DNA adducts and alveolar macrophage cytogenetics. Fundam Appl Toxicol 1993; 20: 393-401.
66. TakenawaJ, Kaneko Y, Okumura K, Nakayama H, Fujita J, Yoshida O. Urinary excretion of mutagens and covalent DNA damage induced in the bladder and kidney after passive smoking in rats. Urology Res 1994; 22: 93-7.
67. Grimmer G, Brune H, Dettbarn G, Naujack K W, Mohr U, Wenzel-Hartung R. Contribution of polycyclic aromatic compounds to the carcinogenicity of sidestream smoke of cigarettes evaluated by implantation into the lungs of rats. Cancer Lett 1988; 43: 173-7.
68. Mohtashamipur E, Mohtashamipur, A, Germann P G, Ernst H, Norpoth K, Mohr U. Comparative carcinogenicity of cigarette mainstream and sidestream smoke condensates on the mouse skin. J Cancer Res Clin Oncol 1990; 116: 604-8.
69. Wynder E L, Hoffmann D. Biological tests for tumorigenic and cilia-toxic activity. In: Tobacco and tobacco smoke: studies in experimental carcinogenesis. New York: Academic Press, 1967; 183-4.
70. Witschi H, Espiritu I, Peake J L, Wu K, Maronpot R R, Pinkerton K E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997; 18: 575-86.
71. Witschi H, Oreffo V I, Pinkerton K E. Six-month exposure of strain A/J mice to cigarette sidestream smoke: cell kinetics and lung tumour data. Fundam Appl Toxicol 1995; 26: 32-40.
72. Coggins R E, Ayres P H, Mosberg A T, Ogden M W, Sagartz J W, Hayes A W. Fourteen-day inhalation study in rats, using aged and diluted sidestream smoke from a reference cigarette: I: inhalation toxicology and histopathology. Fundam Appl Toxicol 1992; 19: 133-40.
73. Coggins C R E, Ayres P H, Mosberg A T, Sagartz J W, Hayes A W. Subchronic inhalation study in rats using aged and diluted sidestream smoke from a reference cigarette. Inhalation Toxicology 1993; 5: 77-96.
74. Sorsa M, Husgafvel-Pursiainen K, Jrventaus H, Koskimies, K, Salo H, Vainio H. Cytogenetic effects of tobacco smoke exposure among involuntary smokers. Mutat Res 1989; 222: 111-16.
75. Crawford F G. Biomarkers and environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst 1994; 86: 1398-1402.
76. Maclure M, Katz R B, Bryant M S, Skipper P L, Tannenbaum S R. Elevated blood levels of carcinogens in passive smokers. Am J Public Health 1989; 79: 1381-4.
77. Hammond S K, Coghlin J, Gann P H et al. Relationship between environmental tobacco smoke exposure in carcinogen-haemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993; 85: 474-7.
78. Bos R P, Theuws J L G, Henderson P T H. Excretion of mutagens in human urine after passive smoking. Cancer Lett 1983; 19: 85-90.
79. Sorsa M, Einisto P. Passive and active exposure to cigarette smoke in a smoking experiment. J Toxicol Environ Health 1985; 16: 523-34.
80. Husgafvel-Pursiainen K, Sorsa M, Engstrm, Einisto P. Passive smoking at work: biochemical and biological measures to exposure to environmental tobacco smoke. Int Arch Occup Environ Health 1987; 59: 337-45.
81. Perera F P, Santella R M. DNA adducts, protein adducts, and sister chromatidexchange in cigarette smokers and nonsmokers. J Natl Cancer Inst 1987; 79: 449-56.
82. Scherer G, Westphal K, Biber A, Koepfner I, Adlkofer F. Urinary mutagenicity after controlled exposure to environmental tobacco smoke (ETS). Toxicol Lett 1987; 35: 135-40.
83. Mohtashamipur E, Mller G, Norpoth K, Endrikat M, Stcker W. Urinary excretion of mutagens in passive smokers. Toxicol Lett 1987; 35: 141-6.
84. Gorgels W J M J, van Poppel G, Jarvis M J, Stenhuis W, Kok F J. Passive smoking and sister-chromatid exchanges in lymphocytes. Mutat Res 1992; 279: 223-38.
85. Autrup H, Vestergaar A B, Okkels H. Transplacental transfer of environmental genotoxins: polycyclic aromatic hydrocarbon-albumin in non-smoking women, and the effect of maternal GSTM1 genotype. Carcinogenesis 1995; 16: 1305-9.
86. Sasson I M, Coleman D T, LaVoie E J, Hoffmann D, Wynder E L. Mutagens in human urine: effects of cigarette smoking and diet. Mutat Res 1985; 158: 149-57.
87. Bartsch H, Caporaso N. Carcinogen haemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers. J Natl Cancer Inst 1990; 82: 1826-31.
88. Phillips D H, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 1990; 46: 569-75.
89. van Schooten F J. Polycyclic aromatic hydrocarbon-DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung. Carcinogenesis 1992; 13: 987-93.
90. Jahnke G D, Thompson C L, Walker M P, Gallagher J E, Lucier G W, DiAugustine R. Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabelling analysis. Carcinogenesis 1990; 11: 205-11.
91. van Maanen J M S, Maas L M, Hageman G, Kleinjans J C S, van Agen B. DNA adduct and mutation analysis in white blood cells of smokers and nonsmokers. Environ Mol Mutagen 1994; 24: 46-50.
92. Farmer P. Biomonitoring and molecular dosimetry of genotoxic carcinogens. In: DeMatteis F, Smith LL, eds. Molecular and cellular mechanisms of toxicity. London: CRC Press, 1995; 101-23.
93. Perera F P. The significance of DNA and protein adducts in human biomonitoring studies. Mutat Res 1988; 205: 255-269.
94. Skipper P L, Tannenbaum S R. Protein adducts in the molecular dosimetry ofchemical carcinogens. Carcinogenesis 1990; 11: 507-18.
95. Reasor M J. Relationship between environmental tobaccos smoke exposure and carcinogen-haemoglobin adduct levels in nonsmokers. J Natl Cancer Inst 1993; 85: 1693-4.
96. Hammond S K, Coghlin J, Gann P H, Skipper P L, Tannenbaum S R. Response to Reasor M J. J Natl Cancer Inst 1993; 85: 1694-6.
97. Carmella S G. Mass spectrometric analysis of tobacco-specific nitrosamine haemoglobin adducts in snuff dippers, smokers and nonsmokers. Cancer Res 1990; 50: 5438-45.
98. Bryant M S, Skipper P L, Tannenbaum S R, Maclure M. Haemoglobin adducts of 4-aminobiphenyl in smokers and nonsmokers. Cancer Res 1987; 47: 602-8.
99. Randerath E, Miller R H, Mittal D, Avitts T A, Dunsford H A, Randerath K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabelling assay. J Natl Cancer Inst 1989; 81: 341-7.
100. Savela K, Hemminki K. DNA adducts in lymphocytes and granulocytes of smokers and nonsmokers detected by the 32P-postlabelling assay. Carcinogenesis 1991; 12: 503-8.
101. Lewtas J. Comparison of DNA Adducts from exposure to complex mixtures in various human tissues and experimental systems. Environ Health Perspect 1993; 99: 89-97.
102. Phillips D H. DNA adducts in human tissues: biomarkers of exposure to carcinogens in tobacco smoke. Environ Health Perspect 1996; 104(suppl 3): 453-8.
103. Kawachi I, Colditz G A. Invited commentary: confounding, measurement error and publication bias in studies of passive smoking. Am J Epidemiol 1996; 144: 909-15.
104. Dockery D W, Trichopoulos D. Risk of lung cancer from environmental exposures to tobacco smoke. Cancer Causes Control 1997; 8: 333-45.
105. Peto J. Meta-analysis of epidemiological studies of carcinogenesis. In: Vainio H, Magee P N, McGregor D B, McMichael A J, eds. Mechanisms of carcinogenesis in risk identification. Lyon: International Agency for Research on Cancer, 1992; 571-7.
106. Wu-Williams A H. Lung cancer among women in north-east China. Br J Cancer 1990; 62: 982-7.
107. Wald N J, Nanchahal K, Thompson S G, Cuckle H S. Does breathing other people's tobacco smoke cause lung cancer? BMJ 1986; 293: 1217-22.
108. Law M R, Hackshaw A K. Environmental tobacco smoke. Br Med Bull 1996; 52: 22-34.
109. Jarvis M. Imperial Cancer Research Fund, Health Behaviour Unit, University College London. Personal communication to COC secretariat. 1997.
110. Jarvis M J, McNeill A. Factors determining exposure to passive smoking in young adults living at home: quantitative analysis using saliva cotinine concentrations. Int J Epidemiol 1991; 20: 126-31.
111. Riboli E. Exposure of nonsmoking women to environmental tobacco smoke: a 10 country collaborative study. Cancer Causes Control 1990; 1: 243-52.
112. Matsukura S. Effects of environmental tobacco smoke on urinary cotinine excretion in nonsmokers: evidence for passive smoking. N Engl J Med 1984; 311: 828-32.
113. Blot W J, Fraumeni J F. Passive smoking and lung cancer. J Natl Cancer Inst 1986; 77: 993-1000.
114. Benowitz N L. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev 1996; 18: 188-204.
115. Trichopolous D. Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA 1992; 268: 1697-1701.
116. Agapitos E. Epithelial, possibly precancerous, lesions of the lung in relation to smoking, passive smoking, and socio-demographic variables. Scand J Soc Med 1996; 24: 259-63.
|
